Chronic infection with hepatitis C virus (HCV) is associated with failures of T-cellmediated immune clearance and with abnormal B-cell growth and activation.HCV infection is characterized by a systemic oxidative stress that is most likely caused by a combination of chronic inflammation, iron overload, liver damage, and proteins encoded by HCV. Following viral infection, multiple pro-inflammatory mediators contribute to recruitment of immune cells to the liver and to the generation of an antiviral immune response. Recent publications mark chemokines and their receptors as key players in leukocyte recirculation through the inflamed liver. The present study involved 75 male subjects, included into two groups: Group1 (n=30) control group; group II (n=45) patients with chronic HCV. For all subjects the following investigations were performed: estimation of the levels of bilirubin, albumin, prothrombin concentration, glycosylated hemoglobin (HbA 1C ), creatinine, α-fetoprotein (AFP), HCV RNA, and activities of alanine and aspartate transaminases (ALT& AST) as well as alkaline phosphatase. Also, Regulated on Activation Normal T Cell Expressed and Secreted (RANTES), tumor necrosis factor alpha (TNF-α), malondialdehyde (MDA) and nitric oxide (NO) were assessed. Plasma HCV-RNA concentration (viral load) was determined by real time PCR step one using Applied Biosystem. Complete blood picture was assayed using Abbott cell dyn 3700 hematology analyzer. There were significant increase of the levels of RANTES,TNF-α, MDA and NO in HCV infected patients compared with control group (P <0.05) and in these patients, these levels showed significant positive correlation with the HCV RNA viral load. Also, mild leucopenia, thrombocytopenia, neutropenia, lymphocytosis, with consequent significant increase in the lymphocytes / neutrophils (L/N) ratio were detected in these patients.
INTRODUCTION
The World Health Organization estimates reported that about 3% of the world's population has been infected with hepatitis C virus (HCV), (WHO) (1) .
HCV is a major human pathogen, infecting more than 170 million individuals; approximately 70% of those infected become chronic carriers and are at severe risk of developing liver fibrosis and cirrhosis (2) . The majority of persons with HCV infection progress to chronic infection, which can lead to hepatic fibrosis and the subsequent occurrence of cirrhosis, liver failure, and hepatocellular carcinoma (3) . During many chronic infections, virus spreads rapidly from the site of initial infection to distal tissues. T cells must first become activated in the lymph nodes and spleen and then gain the ability to migrate to infected organs. Chemokines orchestrate all stages of that T cell response from recruitment of naive T cells to inflamed lymphoid tissue, migration of T cells within lymphoid organs, movement of activated T cells from lymphoid tissues to effector sites, and the movement of effector T cells within non-lymphoid tissues (4) . RANTES (regulated on activation normal T cell expressed and secreted) is a chemokine that play a role in immune responses to viral infections. It was originally considered a T cellspecific chemokine, but now it is known to be expressed by other cell types including epithelial cells and platelets (5) . It is a member of the chemokine family with potent chemotactic properties for T lymphocytes, natural killer (NK), memory T cells, esinophils, dendritic cells and monocytes (5-9) . Production of chemokines in the liver is likely to play a role in HCV infection, as infiltration of lymphocytes has been observed in concomitance with chronic disease (10) . The present study aimed to assess the serum levels of RANTES, TNF-α, complete blood count and oxidative stress markers in patients with hepatitis C and to find if they have a relation to the virus load in these patients.
SUBJECTS & METHODS
The present study included 45 male patients with hepatitis C virus (HCV). They were recruited from the Internal Medicine Department of October 6 University Hospital, beside thirty healthy male subjects, matched for age and body mass index, were recruited as a control group. None showed clinical or biochemical signs of advanced liver or kidney diseases (their plasma prothrombin time, serum albumin and creatinine were within normal ranges).
Twelve ml. blood were withdrawn from each patient and control subject after 10 hours fasting. Blood was withdrawn in sterile syringe, 1.8-ml from the blood sample was taken on 200 µl. sodium citrate, centrifuged, and plasma was separated and used for estimation of prothrombin concentration by clotting method on ٍ◌Stago STA-Compact analyzer-France. Two ml. of the blood sample was placed in vacuum tube containing K 2 EDTA, one ml.
was used as such for estimation of HbA 1c
(16) using automated Hitachi 911, and complete blood counts which were performed in duplicate within 20 minutes of collection by Abbott cellDyn 3700 hematology analyzer. The remaining ml. of the K 2 EDTA sample was centrifuged and the separated plasma was used for estimation of the viral load of HCV in patients using the real time PCR (Figure 1 ). The remaining part of the blood sample was placed in sterile plain tubes, centrifuged and the serum was stored at -70°C until used for estimation of the levels of total bilirubin, albumin, creatinine, nitric oxide, malondialdehyde, and the activities of serum alanine and aspartate transaminases (ALT, AST), and alkaline phosphatase using automated Hitachi 911multichannel analyzer (Boehringer Manheim Diagnostics, Indianapolis).
Hepatitis 
RESULTS
The present study showed significant increase of serum levels of RANTES, TNF-α, MDA and NO in patients with chronic HCV infection compared with control group (Table 1  and figure 2) . Further, these parameters showed significant positive correlations with the HCV load and with the activities of ALT (Table 2) .Also, total leucocytic, platelets and neutrophils mean counts were significantly lower, while lymphocytes mean count was significantly higher in HCV patients compared to controls (Table 1) . In the current study, HCV infected patients showed significantly increased serum levels of stress markers (MDA and NO) and these levels showed significant positive correlation with the HCV RNA viral load.
Ali et al. (33) have shown that serum MDA and NO levels and myeloperoxidase (MPO) activity were significantly higher and the activities of paraoxonase and arylesterase were significantly lower in 23 chronic HCV hepatitis Egyptian patients compared to 21 healthy subjects. Nakhjavani et al.
(34) have reported that oxidative stress and lipid-peroxidation play a major role in liver injury in chronic HCV infection and that viral load correlated with the serum level of oxidized LDL.
Moreover, Ozenirler et al.
have reported that oxidative stress increases in chronic hepatitis patients manifested by increases in MDA. However, antioxidant defense mechanisms may not increase sufficiently and accordingly, therefore, the balance destabilizes in favor of oxidative stress
In the present study, the means count of platelets, total leucocytes, as well as neutrophils were significantly lower, and that of lymphocytes was significantly higher, while those of Hb and erythrocytes were not significantly different in patients with HCV infection compared with controls. Streiff et al. have calculated the lymphocytes/neutrophils (L/N) ratio and found that ratio was significantly higher in HCV infection (0.86) than that of HBV infection (0.56) and of African American controls. Lymphocytosis was defined as ratio of lymphocytes to neutrophils (L/N) above 0.6. L/N ratios were calculated to avoid the impact of hypersplenism and constitutional leucopenia seen in African Americans (AA).
In the present study, the calculated L/N ratio was significantly higher in HCV infected patients (0.795) than controls (0.591), P<0.001 among Egyptians.
Hemoglobin A 1c levels were estimated in the present study to asses the glycemic state of the controls and chronic HCV patients since it is now widely recognized that chronic hepatitis C is a metabolic disease, strongly associated with type 2 diabetes mellitus and insulin resistance 
